Skip to content

Drug interactions

Midostaurin + Siponimod

Severity: Major

Midostaurin and Siponimod: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs may prolong the QT interval, and siponimod may cause bradycardia, increasing the risk of serious ventricular arrhythmia.

What this interaction means in plain words

Midostaurin and Siponimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Midostaurin belongs to Oncology; Siponimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive QT prolongation with siponimod-related bradycardia.

What to do

Obtain a baseline ECG, correct electrolytes, and monitor QTc during therapy. Consider alternatives if QTc becomes prolonged.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Midostaurin and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Midostaurin with Siponimod?

MediHelp rates the interaction as major. Midostaurin and Siponimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs may prolong the QT interval, and siponimod may cause bradycardia, increasing the risk of serious ventricular arrhythmia.

How serious is the interaction between Midostaurin and Siponimod?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG, correct electrolytes, and monitor QTc during therapy. Consider alternatives if QTc becomes prolonged.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in